论文部分内容阅读
欧盟批准Schering-Plough公司的非镇静性抗组胺药地洛他定（desloratadine）糖浆剂上市用于成人和2岁及以上儿童的季节性变态反应、慢性特发性荨麻疹（CIU）症状如发痒或荨麻疹的一日1次治疗。并且批准地洛他定速崩片用于成人和12岁及以上少年的季节性变态反应、CIU的治疗。
EU Approves Schering-Plow’s Non-Sedation Antihistamine Drugs Desloratadine syrup is available for seasonal allergy, chronic idiopathic urticaria (CIU) symptoms in adults and children 2 years and older Itch or urticaria once a day treatment. And approved dextro-bolus disintegrating tablets for the treatment of seasonal allergies, CIU, in adults and adolescents aged 12 and over.